Open AccessTHREE-MONTH RESULTS OF A PHASE 2 TRIAL EVALUATING CLAZAKIZUMAB IN LATE ANTIBODY-MEDIATED REJECTION – EARLY IMPACT OF IL-6 BLOCKADE ON DONOR-SPECIFIC ANTIBODY LEVELS, REJECTION MORPHOLOGY AND GENE EXPRESSION
Author(s) -
Georg A. Böhmig,
Michael Dürr,
Bernd Jilma,
Farsad Eskandary,
Edward Chong,
Sabine Schranz,
Konstantin Doberer,
Markus Wahrmann,
Anita Borski,
Heinz Regele,
Johannes Kläger,
J. Reeve,
Klemens Budde,
Philip F. Halloran
Publication year - 2020
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000700336.56990.fa
Subject(s) - medicine , interquartile range , placebo , gastroenterology , randomized controlled trial , biopsy , urology , antibody , immunology , pathology , alternative medicine